Research Chemical Designation & Liability

Compounds indexed in the MinMaxMuscle archive are strictly for laboratory research and development. They are NOT approved for human consumption. Theoretical dosing data is aggregated from clinical literature and must not be construed as medical instruction. Professional medical consultation is mandatory prior to any research application.

Full Disclaimer
Archive Identifier

Epitalon

Longevity

Molecular Dossier

  • Rank Index: 20
  • Status: FDA Category 2
  • What does this mean?
  • Molecular Structure: Tetrapeptide (Ala-Glu-Asp-Gly)

About Epitalon

A synthetic tetrapeptide researched for its ability to regulate telomerase and improve sleep quality.

Clinical Focus

Longevity & Sleep

Archival Aliases

Telomere Peptide, Epithalon

Frequently Asked Questions

What are the strict legal and safety limitations for research-grade peptides?

All products listed in this research database are intended solely for laboratory research purposes and are not for human or animal consumption, diagnostic, or therapeutic use. As a researcher, it is your responsibility to ensure that all experimental protocols comply with local and federal regulations. These compounds are provided in lyophilized form to maintain chemical stability and must be handled by qualified professionals in a controlled environment. Any use outside of a supervised laboratory setting is strictly prohibited and violates the intended research application of these materials.

What are the potential risks of improper peptide handling in a research environment?

Improper handling of peptides can lead to rapid degradation, loss of potency, or chemical contamination. Exposure to high temperatures, direct sunlight, or physical agitation (shaking the vial) can break the delicate peptide bonds, rendering the research sample useless for data collection. Furthermore, using non-sterile solvents or failing to maintain a cold chain during transport can introduce bacterial pathogens. Researchers must prioritize aseptic techniques and precise reconstituting protocols to ensure the integrity of the experimental results and the longevity of the research material.

What is the "Telomerase Theory" behind Epitalon?

Epitalon is a tetrapeptide that induces telomerase activity in somatic cells. By elongating telomeres, it allows cells to exceed the Hayflick limit (the number of times a cell can divide), theoretically extending the lifespan of the cell line and delaying cellular senescence in longevity research.

What is epitalon and who developed it?

Epitalon (Epithalamine) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology in Russia. It is a synthetic version of the naturally occurring polypeptide epithalamin, isolated from the pineal gland. Khavinson's research group has published extensively on its life-extension properties in both animal models and human longitudinal studies spanning over 40 years.

How does epitalon activate telomerase?

Epitalon stimulates the expression of telomerase reverse transcriptase (hTERT), the catalytic subunit of the telomerase enzyme. Telomerase elongates telomeres — the protective caps at the ends of chromosomes that shorten with each cell division. Studies in human fetal fibroblast and somatic cell cultures show that epitalon treatment can extend telomere length and delay replicative senescence. This is one of the few peptides with published evidence for direct telomere maintenance.

What does the human longevity data on epitalon show?

Khavinson's longitudinal studies in elderly patients (ages 60-80) treated with epithalamin/epitalon over 3-6 years showed 1.6-1.8x reduction in mortality compared to control groups. While these studies are not double-blind RCTs by Western standards, they represent the longest observational dataset for any peptide compound. Animal studies in mice and fruit flies consistently show 25-33% lifespan extension.

Does epitalon affect melatonin and sleep?

Yes. The pineal gland's primary output is melatonin, which declines with age. Epitalon restores pineal function and has been shown to normalize melatonin secretion in elderly subjects toward more youthful levels. Improved melatonin rhythm restoration improves circadian entrainment, sleep quality, and the downstream immune and hormonal benefits of restorative sleep. This is separate from its telomerase-activating properties.

How is epitalon typically cycled in research?

The protocols documented in Khavinson's research involve concentrated cycles: typically 5-10mg daily for 10-20 consecutive days, administered via subcutaneous injection or intramuscularly. This "pulse" approach is repeated 1-2 times per year. Some researchers use intranasal administration. Long-term continuous use has not been extensively studied in healthy populations.

Does epitalon have anti-cancer properties?

Preclinical data suggests epitalon may reduce carcinogenesis in animal models. Studies in mice exposed to carcinogens show reduced tumor incidence in epitalon-treated groups. The proposed mechanism involves DNA repair enhancement, antioxidant gene activation (particularly SOD and glutathione peroxidase upregulation), and restoration of immune surveillance through normalized neuroendocrine function. These findings have not been confirmed in human clinical trials.

What is epitalon's effect on hormonal axes?

Epitalon appears to normalize the function of the hypothalamic-pituitary axis in aging subjects. Studies show improved regulation of cortisol, thyroid hormone, and sex hormone binding globulin. The pineal-hypothalamic connection means that restoring pineal peptide output has broad downstream hormonal effects. It is sometimes used in anti-aging protocols alongside other pineal bioregulators like Pinealon for synergistic effects.

Clinical Data Matrix

Parameter Clinical Value
Molecular Weight Tetrapeptide (Ala-Glu-Asp-Gly)
Primary Pathway Longevity
Research Phase FDA Category 2

Clinical Pros

  • Highly selective receptor modulation
  • Documented efficacy in Phase II trials
  • Minimal systemic cross-reactivity

Research Limitations

  • Limited long-term human data
  • Strict storage and reconstitution requirements
  • Potential for acute homeostatic feedback loops

Community Discussion

Share your questions and experiences with other researchers in the forum.

Discuss in Forum

Data Verified: 2026-04-10

Synergistic Matrix